The methylation-sensitive TFs in these triplets were involved in various biological processes previously implicated in AD, such as TGFβ signaling (SMAD3)42, lipid metabolism (SREBF1)43, inflammatory response (CEBPB, XBP1), and cell cycle control (MYC). This evidence concerns the gene SREBF1 and Alzheimer disease.